Just one month into the year, and 2023 already is looking different from 2022. Last January, more than a dozen investment firms participated in 10 or...
OPGN has seen its SMA50 which is now -32.20%. In looking the SMA 200 we see that the stock has seen a -74.62%. VIRI has seen...
VERB has seen its SMA50 which is now 21.37%. In looking the SMA 200 we see that the stock has seen a -49.42%. LCTX has seen...
AKBA has seen its SMA50 which is now 111.80%. In looking the SMA 200 we see that the stock has seen a 179.00%. GNUS has seen...
MGTA has seen its SMA50 which is now 15.01%. In looking the SMA 200 we see that the stock has seen a -35.84%. GETR has seen...
VTGN has seen its SMA50 which is now 71.45%. In looking the SMA 200 we see that the stock has seen a -41.04%. APCA has seen...
SQL has seen its SMA50 which is now 284.08%. In looking the SMA 200 we see that the stock has seen a 117.76%. LUMN has seen...
WINSTON-SALEM, NC, Feb. 7, 2023 – Immunaeon is the latest addition to the RegeneratOR Innovation AcceleratOR, located in the Regenerative Medicine Hub...
Hokkaido University researchers have developed a novel method to design and develop peptide antibiotics in large numbers, which will prove critical to...
“CD200 expression is reported across most cancer types […]” Credit: 2023 Shao and Owens. “CD200 expression is reported across most cancer types...